Skip to main content Skip to section navigation Skip to footer
Aethlon Medical, Inc. Corporate Home
  • The Hemopurifier®
    • Overview
    • The Hemopurifier® in Cancer
    • The Hemopurifier® in Infectious Disease
  • About
    • Overview
    • Leadership
    • Board of Directors
  • News & Media
    • Press Releases
    • Presentations
    • Events
    • Publications
    • Training Videos
  • Investors
    • Overview
    • Corporate News / Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
    • Analyst Coverage
  • Contact Us
Site Announcement

Aethlon Medical is closely monitoring the Bird Flu situation and stands ready to work alongside hospitals, health agencies and the FDA if existing therapies prove inadequate.

Investors
  • Overview
  • Corporate News / Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Presentations
    • Leadership
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Overview
    • Quote
    • Charts
    • Historical Data
    • IRS Form 8937 for 2019 Reverse Stock Split
    • IRS Form 8937 for 2023 Reverse Stock Split
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Governance Documents
  • Analyst Coverage

Press Releases

  • Corporate News / Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Feb 26, 2015

Aethlon Medical Announces First Patient Completes Hemopurifier® Clinical Study Protocol

Feb 24, 2015

Aethlon Medical, Inc. - CTE Data Presentation at the Upcoming 2015 TBI Conference

Feb 12, 2015

Aethlon Medical, Inc. - A Publication Describing the First Treatment of Ebola with the Aethlon Hemopurifier®

Feb 5, 2015

Aethlon Medical, Inc. - The Launch of a Clinical Program That Re-Thinks the Treatment of Viral Pathogens

Jan 8, 2015

Aethlon Medical to Present at Biotech Showcase 2015

Jan 2, 2015

Aethlon Medical Announces Approval of Ebola Treatment Protocol

Dec 11, 2014

Aethlon Medical Initiates Patient Recruitment for FDA Approved Clinical Study

Dec 2, 2014

Aethlon Medical® Reports Rapid and Sustained Virologic Response Rates in Hepatitis C (HCV) Treated Patients

Nov 26, 2014

Aethlon Medical Announces $3.3 Million Equity Investment

Nov 26, 2014

Aethlon Medical Announces First Hemopurifier® Shipment To Support the Treatment of Ebola in the United States

  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Page 23
  • Page 24
  • Page 25
  • Page 26
  • Next Pagearrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
Linkedin
Privacy Policy Disclaimer Sitemap Accessibility Statement
©2025 Aethlon Medical, Inc. All Rights Reserved.